Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Return on Capital Employed (2024 - 2025)

Historic Return on Capital Employed for Mereo BioPharma (MREO) over the last 2 years, with Q3 2025 value amounting to 0.9%.

  • Mereo BioPharma's Return on Capital Employed fell 4000.0% to 0.9% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.9%, marking a year-over-year decrease of 4000.0%. This contributed to the annual value of 0.82% for FY2024, which is 3700.0% down from last year.
  • As of Q3 2025, Mereo BioPharma's Return on Capital Employed stood at 0.9%, which was down 4000.0% from 0.8% recorded in Q2 2025.
  • Over the past 5 years, Mereo BioPharma's Return on Capital Employed peaked at 0.5% during Q3 2024, and registered a low of 0.9% during Q3 2025.